Skip to main content
. 2024 Nov 14;122(Suppl 1):152–172. doi: 10.1159/000542482

Table 6.

Pooled effect estimates associated with meconium aspiration syndrome

Outcome Group # of studies (# of participants) Effect Estimate (95% CI) Heterogeneity (I2) Test for subgroup differences
Endotracheal Suctioning versus Oro-(naso)pharyngeal Suctioning
All-cause neonatal mortality Total 4 (575) RR 1.24 (0.76, 2.02) 12%
Incidence of meconium aspiration syndrome Total 4 (575) RR 1.00 (0.80, 1.25) 49%
Hypoxic ischemic encephalopathy (HIE) Total 2 (327) RR 0.86 (0.62, 1.18) 41% p = 0.19
Any severity 1 (152) RR 1.05 (0.68, 1.63)
Moderate to severe 1 (175) RR 0.68 (0.43, 1.09)
Culture positive sepsis Total 3 (406) RD 0.01 (−0.04, 0.06) 0%
Antibiotics – Comparison 1: Among symptomatic infants
Mortality (before discharge) Total 2 (186) RD 0.01 (−0.03, 0.05) 0%
Incidence of confirmed sepsis in the first 28 days Total 2 (186) RD 0.01 (−0.04, 0.06) 0%
Antibiotics – Comparison 2: Among asymptomatic infants
Mortality (before discharge) Total 1 (250) RR 1.07 (0.22, 5.18)
Incidence of meconium aspiration syndrome Total 1 (250) RR 1.17 (0.67, 2.04)
Incidence of confirmed sepsis in the first 28 days Total 1 (250) RD −0.01 (−0.07, 0.04)
Bolus Surfactant versus Control
Mortality Total 1 (61) RR 0.32 (0.04, 2.93)